← Eichor
Condition: Chronic Active Epstein Barr Virus Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Chronic Active Epstein Barr Virus Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders
Phase 2 · 2 location(s) · Fudan University · NCT07381738Golidocitinib Combined With Selinexor for CAEBVD
Phase 2/Phase 3 · 1 location(s) · Beijing Friendship Hospital · NCT07369739Genetic Studies of Chronic Active Epstein-Barr Disease
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00032513Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r
Phase 1 · 23 location(s) · Imugene Limited · NCT03666000A Registry for People With T-cell Lymphoma
Phase N/A · 26 location(s) · Memorial Sloan Kettering Cancer Center · NCT05978141
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.